| Literature DB >> 32429471 |
Yuhao Zeng1, Satoshi Komasa1, Hisataka Nishida2, Akinori Agariguchi1, Tohru Sekino2, Joji Okazaki1.
Abstract
Alkali-treated titanate layer with nanonetwork structures (<span class="Disease">TNS) is a promising surface for improving osseointeg<span class="Species">ration capacity in implants. Nevertheless, there is a risk of device failure as a result of insufficient resistance to biofilm contamination. This study tested whether treatment using a handheld non-thermal plasma device could efficiently eliminate biofilm contamination without destroying the surface nanostructure while re-establishing a surface that promoted new bone generation. TNS specimens were treated by a piezoelectric direct discharge (PDD) plasma generator. The effect of decontamination was performed utilizing Staphylococcus aureus. The evaluation of initial cell attachment with adhesion images, alkaline phosphatase activity, extracellular matrix mineralization, and expression of genes related to osteogenesis was performed using rat bone marrow mesenchymal stem cells, and the bone response were evaluated in vivo using a rat femur model. Nanotopography and surface roughness did not significantly differ before and after plasma treatments. Cell and bone formation activity were improved by TNS plasma treatment. Furthermore, plasma treatment effectively eliminated biofilm contamination from the surface. These results suggested that this plasma treatment may be a promising approach for the treatment of nanomaterials immediately before implantation and a therapeutic strategy for peri-implantitis.Entities:
Keywords: alkali-treated titanium; biofilm inhibition; nanoporous network structures; non-thermal plasma treatment; osseointegration; peri-implantitis
Mesh:
Substances:
Year: 2020 PMID: 32429471 PMCID: PMC7278937 DOI: 10.3390/ijms21103533
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Scanning electron micrographs of (A) Titanate layer with nanonetwork structures (TNS) and (B) plasma-TNS; Scanning probe micrographs and a typical surface profile of (C,F) TNS and (D,G) plasma-TNS. (E) The measurement of the contact angle on the surface of TNS and plasma-TNS. Data shown are the means ±SD (n = 3). *** p < 0.001.
Roughness values of the TNS and plasma-TNS. Data shown are the means ±SD (n = 3).
| Group | Parameters | |
|---|---|---|
| Ra (nm) | Rz (nm) | |
| TNS | 24.71 ± 7.14 | 218.93 ± 89.48 |
| Plasma-TNS | 27.16 ± 5.01 | 233.90 ± 19.79 |
Figure 2XPS analysis on the surface of TNS and plasma-TNS presented as the mean calculated from the random location of three samples: (A) oxygen/titanium ratio, (B) carbon/titanium ratio, (C) nitrogen/titanium ratio, (D) Wide-survey XPS spectra of the specimens, (E) high-resolution spectra of carbon 1 s, (F) high-resolution spectra of nitrogen 1 s, and high-resolution spectra of oxygen 1 s on the surface of (G) TNS and (H) plasma-TNS, respectively.
Figure 3Effect of plasma treatment on decontamination. Data shown are the means ±SD (n = 3). *** p < 0.001.
Figure 4Determination of intracellular reactive oxygen species of rat bone marrow mesenchymal stem cells attached to the TNS and plasma-TNS disks. Data shown are the means ±SD (n = 3). * p < 0.05.
Figure 5Morphological analysis of rBMMSCs attached to the (A,C) TNS and (B,D) plasma-TNS disks, (E) cell area, values were presented as mean ±SD of three representative images measured as per the surface of three samples in each group, (F) cell adhesion on TNS and plasma-TNS disks at 37 °C. Data shown are the means ±SD (n = 3). *** p < 0.001; ** p < 0.01.
Figure 6(A) Alkaline phosphatase activity, (B) calcium deposition, (C) bone morphogenetic protein 2 (BMP-2) and (D) osteocalcin (OCN) in cells grown on sample disks. Data shown are the means ±SD (n = 3). *** p < 0.001; ** p < 0.01; * p < 0.05.
Figure 7Reconstructed three-dimensional microcomputed tomography transverse slices of rat femurs containing TNS (A) and plasma-TNS (B) implants. The implant, cortical bone, and cancellous bone are shown in red, blue, and green, respectively. (C) Bone volume to total volume ratio (BV/TV), (D) mean trabecular number (Tb.N), (E) mean trabecular separation (Tb.Sp), and (F) mean trabecular thickness (Tb.Th) around implants after eight weeks. Data shown are the means ± SD (n = 3). *** p < 0.001; ** p < 0.01.
Figure 8Villanueva staining of bone tissues around (A) TNS and (B) plasma-TNS implants. Fluorescence labeling of new bone and mineralization around (C) TNS and (D) plasma-TNS implants. (E) Bone area ratio (BA) and (F) bone-implant contact (BIC) of TNS and plasma-TNS implants. Fluorescently labeled bone area (LBA) after (G) one week, (H) four weeks, and (I) eight weeks. Data shown are the means ±SD (n = 3). *** p < 0.001; ** p < 0.01; * p < 0.05.